REBOA stands for Resuscitative Endovascular Balloon Occlusion of the Aorta, and it is exactly what the name describes: a deflated balloon threaded through an artery in the groin, advanced up into the aorta, and inflated to block blood flow below that point. The goal is to keep blood circulating to the heart and brain when a patient is bleeding to death from injuries or conditions below the diaphragm. Originally a niche military concept from the Korean War era, REBOA has surged in civilian trauma practice over the past decade, but its role remains fiercely debated after a landmark randomized trial raised the possibility that it could do more harm than good in certain settings.
What the Procedure Actually Does
When someone is hemorrhaging from the abdomen, pelvis, or a junctional wound that you cannot compress with your hands, the body’s blood pressure can collapse within minutes. REBOA works by temporarily damming the aorta so that whatever blood volume remains preferentially supplies the brain and heart. During CPR, inflating the balloon increases the afterload on the left ventricle, which raises coronary and cerebral perfusion pressure and improves the odds of getting a heartbeat back.1Journal of Cardiothoracic and Vascular Anesthesia. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): Looking Back, Moving Forward In non-traumatic cardiac arrest patients, balloon inflation has been shown to significantly raise peripheral arterial pressures, suggesting improved central circulation during chest compressions.2PubMed Central. Changes in peripheral arterial blood pressure after resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic cardiac arrest patients
The procedure itself involves puncturing the femoral artery in the groin, sliding in a sheath, and advancing a balloon catheter up into the correct segment of the aorta. In many emergency settings this is done without fluoroscopy, relying instead on external body landmarks and ultrasound confirmation. For a zone 1 placement, clinicians estimate catheter length by measuring from the groin access site to the level of the nipples, routing the measurement through the umbilicus.3Trauma Surgery & Acute Care Open. Placement accuracy of resuscitative endovascular balloon occlusion into the target zone with external measurement Some centers use a protocol where ultrasound confirms the guidewire is in the abdominal aorta and verifies balloon position after inflation, with radial artery pressure serving as a real-time monitor.4PubMed. Ultrasound-Guided Resuscitative Endovascular Balloon Occlusion of the Aorta in the Resuscitation Area
The Three Zones of the Aorta
The aorta is divided into three zones for REBOA purposes, and getting the balloon into the right one matters enormously. Zone 1 sits in the descending thoracic aorta, between the left subclavian artery and the celiac trunk. Inflating a balloon here blocks flow to virtually everything below the diaphragm and is used when the source of bleeding is abdominal. Zone 3 is the infrarenal aorta, below the renal arteries, and is used for pelvic or junctional hemorrhage where you want to preserve blood flow to the kidneys and gut. Zone 2, between the renal arteries and the celiac trunk, is generally avoided because occluding there risks kidney and intestinal damage without a clear clinical benefit.5PubMed Central. Anatomical landmarks for safely implementing resuscitative balloon occlusion of the aorta (REBOA) in zone 1 without fluoroscopy
The clinical stakes of misplacement are real. If the balloon drifts into zone 2 or partially occludes the renal arteries, you introduce organ damage to a patient who is already on the edge. External landmarks help, but body habitus varies, and placement accuracy under the chaos of a trauma bay is imperfect.
REBOA Versus Cracking the Chest Open
Before REBOA, the main option for a patient bleeding out from torso injuries was a resuscitative thoracotomy, often called an “emergency department thoracotomy” or simply “cracking the chest.” This involves cutting into the chest, opening the pericardium, and manually clamping the aorta. It is brutally invasive, requires substantial surgical skill, and carries mortality rates that often exceed 90 percent.
Head-to-head comparisons consistently favor REBOA. A matched study of patients in level I trauma centers found that zone 1 REBOA was associated with significantly lower mortality than resuscitative thoracotomy: about 79 percent versus 93 percent. After adjusting for confounders like traumatic brain injury and chest injury severity, thoracotomy was associated with a 25 percent higher relative risk of death.6JAMA Surgery. Zone 1 Endovascular Balloon Occlusion of the Aorta vs Resuscitative Thoracotomy for Patient Resuscitation After Severe Hemorrhagic Shock Another analysis reported that the odds of dying were roughly three times higher with thoracotomy compared to REBOA in patients with traumatic brain injury.7Trauma Surgery & Acute Care Open. Resuscitative endovascular balloon occlusion of the aorta (REBOA) may be superior to resuscitative thoracotomy (RT) in patients with traumatic brain injury (TBI) A separate single-center study found REBOA mortality at about 59 percent compared to 90 percent for thoracotomy.8PubMed Central. A Comparative Analysis of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), Resuscitative Thoracotomy, and Nonprocedural Care for the Management of Life-Threatening Traumatic Torso Hemorrhage
These numbers look compelling, but context matters. All of these are observational comparisons, not randomized trials. The patients selected for REBOA may differ systematically from those who end up getting a thoracotomy. Still, the direction of the evidence is consistent enough that many trauma surgeons view REBOA as a preferable bridge to definitive surgery when the anatomy of the injury permits it.
The UK-REBOA Trial and Why It Shook the Field
In 2023, the UK-REBOA trial became the first randomized controlled trial of REBOA in trauma, and the results were not what advocates expected. Among patients with exsanguinating hemorrhage, those who received REBOA plus standard care had a 90-day mortality of 54 percent, compared to 42 percent in the standard-care-alone group. The odds ratio was 1.58, and the posterior probability that REBOA increased the odds of death was about 87 percent. Bleeding-related deaths were also more common in the REBOA group, particularly within the first 24 hours.9PubMed Central. Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial
The secondary outcomes reinforced the concern. The posterior probability of harm grew stronger at earlier time points, meaning the signal of increased mortality was most pronounced in the hours immediately after the procedure. The full health technology assessment confirmed these findings and noted that the probability of REBOA being harmful was consistently higher than the probability of benefit across virtually all endpoints.10PubMed Central. The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT
The trial was small, with only 89 patients randomized, and critics have pointed to several concerns: the participating centers had relatively limited REBOA experience, there may have been delays in definitive hemorrhage control while clinicians were occupied placing the balloon, and the patient population may not reflect settings where REBOA is most likely to help (such as prolonged transport times or austere environments). The debate is far from settled, but the trial forced the trauma community to grapple with the possibility that a procedure which makes physiological sense on paper could still cause net harm in practice if it delays other interventions or introduces complications.
The Ischemia Clock
The fundamental trade-off with REBOA is time. Every minute the balloon is inflated, everything below it is starved of oxygenated blood. When the balloon eventually comes down, reperfusion floods those tissues with oxygen and triggers an inflammatory cascade. Prolonged zone 1 occlusion is closely linked to systemic inflammation, metabolic acidosis, organ dysfunction, and spinal cord injury.11PubMed Central. Mild Therapeutic Hypothermia Reduces Ischemia-Reperfusion Injury After Zone 1 REBOA in a Swine Hemorrhagic Shock Model Kidney failure and multisystem organ failure are among the most feared downstream consequences.12Open Anesthesia. Resuscitative Endovascular Balloon Occlusion of the Aorta – Section: Complications of REBOA
In a primate model, 60 minutes of unopposed zone 1 balloon inflation resulted in paralysis from spinal cord ischemia in half of the animals. Limiting inflation to 30 minutes eliminated that complication entirely.13PubMed. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): Zone I Balloon Occlusion Time Affects Spinal Cord Injury in the Nonhuman Primate Model That finding has shaped the clinical consensus that occlusion time should be kept as short as possible, ideally under 60 minutes and preferably much less. The balloon is a bridge, not a destination.
Partial Occlusion as a Workaround
One approach to limiting ischemic damage is not inflating the balloon all the way. Partial REBOA (sometimes called P-REBOA) leaves some blood trickling past the balloon, providing enough proximal pressure to keep the brain and heart perfused while reducing the metabolic hit to the organs below. In a swine model, complete occlusion produced supraphysiologic blood pressure spikes followed by severe rebound hypotension when the balloon was deflated, along with elevated lactate and visible duodenal tissue death on histology. Partial occlusion achieved more modest blood pressure support with none of the intestinal necrosis seen in the full-occlusion animals.14PubMed. Partial Resuscitative Endovascular Balloon Occlusion of the Aorta in Swine Model of Hemorrhagic Shock
Partial REBOA is technically more demanding. The operator must titrate balloon volume against real-time blood pressure readings, adjusting continuously. In a chaotic trauma resuscitation, that added complexity is nontrivial. But it represents the direction the field is moving: trying to capture the hemodynamic benefit of aortic occlusion while minimizing the biological cost. A case report of a ruptured abdominal aortic aneurysm managed with partial REBOA demonstrated that hemodynamic stability could be maintained while buying time for surgical repair.15PubMed Central. Ruptured abdominal aortic aneurysm managed using resuscitative endovascular balloon occlusion of the aorta with a two-stage approach
Vascular Access Complications
Threading a catheter into the femoral artery of a patient in hemorrhagic shock is not a gentle procedure, and the access site itself is a source of complications. A meta-analysis found a pooled vascular access complication rate of about 9 percent, with substantial variation across studies. Traumatic hemorrhage patients had a significantly higher complication risk than non-trauma patients.16PubMed. Systematic Review and Meta-Analysis of Lower Extremity Vascular Complications after Arterial Access for Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): An Inevitable Concern? A national analysis of percutaneous REBOA cases found a 7 percent complication rate, with hematoma being the most common, followed by pseudoaneurysm.17Journal of Surgical Research. National Analysis of Vascular Access Site Complications and Associated Factors in Percutaneous Resuscitative Endovascular Balloon Occlusion of the Aorta
Among REBOA survivors, limb ischemia related to the access site has been reported in nearly 9 percent, encompassing extremity ischemia, distal embolism, and combinations of both. One study found femoral artery dissection in 8 percent of patients and thrombosis in 4 percent. Strikingly, patients who received REBOA through smaller 7-French sheaths had zero access complications in that same cohort.18PubMed Central. Complications associated with the use of resuscitative endovascular balloon occlusion of the aorta (REBOA): an updated review
Smaller Devices, Fewer Problems
The shift toward smaller-bore catheters has been one of the clearest practical improvements in REBOA technology. Early devices required large-bore sheaths (12 French or bigger), which essentially meant punching a sizable hole in the femoral artery. Newer 7-French compatible devices can be placed through a much smaller puncture. Data from a Japanese multicentre registry found that smaller sheaths appeared to produce fewer complications despite longer dwell times.19Emergency Medicine Journal. Fewer REBOA complications with smaller devices and partial occlusion: evidence from a multicentre registry in Japan A study specifically evaluating 7-French catheters found they could significantly elevate blood pressure with no access-related complications, and could safely remain in place during ongoing resuscitation.20Journal of Trauma and Acute Care Surgery. Smaller introducer sheaths for REBOA may be associated with fewer complications
A four-year single-center experience with low-profile 7-to-8-French devices reported very few serious access-related events, though distal embolization and renal failure still occurred occasionally.21PubMed Central. Low profile REBOA device for increasing systolic blood pressure in hemodynamic instability: single-center 4-year experience of use of ER-REBOA Smaller is not risk-free, but the complication profile looks meaningfully better than the older large-bore approach.
Uses Beyond Trauma
While trauma resuscitation gets most of the attention, REBOA has found footholds in several other clinical scenarios where massive hemorrhage threatens life.
Obstetric Hemorrhage
Placenta accreta spectrum disorders, where the placenta grows abnormally deep into the uterine wall, can cause catastrophic bleeding during cesarean delivery. Several studies have evaluated prophylactic REBOA placement during planned cesarean hysterectomies for these patients. After adjusting for risk factors, one study found that distal zone 3 balloon occlusion reduced estimated blood loss by about 46 percent and cut red blood cell transfusion volume by roughly 42 percent, with no REBOA-related vascular complications.22PubMed Central. Aortic balloon occlusion in distal zone 3 reduces blood loss from obstetric hemorrhage in placenta accreta spectrum Another study found that only about 18 percent of REBOA patients needed four or more units of red blood cells, compared to nearly half of those without REBOA, and the REBOA group also had lower rates of postoperative bowel complications.23Trauma Surgery & Acute Care Open. When the balloon goes up, blood transfusion goes down: a pilot study of REBOA in placenta accreta spectrum disorders A separate retrospective cohort confirmed that REBOA decreased blood loss during these surgeries without meaningfully increasing operative time.24PubMed. Prophylactic resuscitative endovascular balloon occlusion of the aorta use during cesarean hysterectomy for placenta accreta spectrum: a retrospective cohort study
Cardiac Arrest
The idea of using REBOA during non-traumatic cardiac arrest, such as a heart attack in the field, is provocative. A Norwegian helicopter emergency service demonstrated that REBOA was feasible during out-of-hospital cardiac arrest, achieving successful placement in all ten patients attempted, with 80 percent success on the first cannulation try and a mean procedure time under 12 minutes. End-tidal CO2, a proxy for how well blood is circulating centrally, jumped significantly after balloon inflation. Six of the ten patients achieved return of spontaneous circulation.25PubMed Central. Feasibility of Pre-Hospital Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-Traumatic Out-of-Hospital Cardiac Arrest A pig model of cardiac arrest showed a trend toward more animals regaining a heartbeat with REBOA (five out of ten versus one of ten in controls), along with better blood gas values, though the differences did not reach statistical significance in that small sample.26PubMed Central. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic cardiac arrest in a pig-model
Ruptured Aortic Aneurysms
When an abdominal aortic aneurysm ruptures, patients bleed internally and can lose their blood pressure within minutes. REBOA can serve as a rapid bridge while the surgical team prepares for definitive repair. A propensity-matched cohort study of ruptured aneurysm repairs found that REBOA had a 100 percent technical success rate and was associated with a significantly reduced rate of major adverse cardiovascular events compared to matched controls (about 5 percent versus 21 percent), along with higher intraoperative diastolic blood pressure. Thirty-day mortality did not differ significantly between the groups.27PubMed. Perioperative Outcomes and Safety of Resuscitative Endovascular Balloon Occlusion of the Aorta in Ruptured Abdominal Aortic Aneurysm Repair: A Propensity-Matched Cohort Study
Who Should and Should Not Get REBOA
Patient selection is critical. The primary candidates are patients with traumatic cardiac arrest or significant intra-abdominal bleeding from solid organ injuries or unstable pelvic fractures. The absolute contraindications are injuries to the aorta itself and cardiac injury with or without tamponade, because inflating a balloon proximal to those injuries could make things dramatically worse.28PubMed Central. Resuscitative endovascular balloon occlusion of the aorta in trauma management: a comprehensive study of clinical indications and challenges
Beyond the absolute contraindications, practical considerations shape patient selection. Patients with severe peripheral vascular disease may not have femoral arteries that can accommodate a sheath. Patients whose bleeding source is above the diaphragm, such as a thoracic great vessel injury, will not benefit from blocking flow below it. And patients who are so far gone that no intervention is likely to help represent a situation where the time spent placing the balloon may be better spent elsewhere.
Prehospital REBOA
One of the most tantalizing applications is deploying REBOA before the patient ever reaches a hospital. In military settings and in civilian helicopter emergency services, particularly in Scandinavia, prehospital REBOA has been attempted with some success. A systematic review concluded that prehospital REBOA is feasible and can serve as an effective resuscitative tool for patients with lethal non-compressible torso hemorrhage, though the evidence base remains thin and heterogeneous.29Trauma Care. The Role of Prehospital REBOA for Hemorrhage Control in Civilian and Military Austere Settings: A Systematic Review
The practical barriers are significant. Limited space, poor lighting, cold weather, scarce personnel, and unstable environments all interfere. One systematic review of civilian prehospital programs noted that even with strict protocols, multiple eligible patients did not receive REBOA due to field conditions.30PubMed Central. Resuscitative endovascular balloon occlusion of the aorta in civilian pre-hospital care: a systematic review of the literature Performing a percutaneous femoral artery puncture in the back of a helicopter or on a roadside at night is a different challenge from doing it in a well-lit trauma bay with a full team.
The Training Problem
REBOA is a low-frequency, high-stakes procedure at most institutions, and that creates a training challenge. Skills degrade without practice. A study tracking trauma faculty and fellows after a REBOA training course found that knowledge scores improved significantly right after training and held steady at six months, but by one year had dropped back to baseline levels. Subjective comfort with the procedure started declining even earlier, particularly among clinicians who had not performed any clinical REBOA cases in the interim.31PubMed. The REBOA Dissipation Curve: Training Starts to Wane at 6 Months in the Absence of Clinical REBOA Cases A separate study found that skill degradation was most pronounced in trainees who went more than five months without any training refresher.32European Journal of Trauma and Emergency Surgery. Resuscitative endovascular balloon occlusion of the aorta: simulation improves performance but may require interval training to prevent skill degradation
This has real implications for which hospitals should maintain REBOA programs. A center that sees only a handful of cases per year may struggle to keep its team proficient. One institution’s first-year experience with nine REBOA patients found a complication rate of about 44 percent, a sobering reminder that early adoption curves are steep for invasive resuscitative procedures.33Journal of Endovascular Resuscitation and Trauma Management. Hate to Burst Your Balloon: Successful REBOA Use Takes More Than a Course
Cost-Effectiveness
The economics of REBOA are tangled. Compared to resuscitative thoracotomy, REBOA tends to produce more quality-adjusted life years gained, but at higher cost. One analysis found REBOA’s average cost per case was roughly $50,000 versus $21,000 for thoracotomy, but the cost per quality-adjusted life year was actually lower for REBOA ($1,248 versus $3,929), making it cost-effective by conventional thresholds.34Journal of the American College of Surgeons. Resuscitative Endovascular Balloon Occlusion of the Aorta is Cost-Effective in the Management of the Unstable Trauma Patient A UK-based analysis reached a different conclusion, finding that REBOA exceeded the National Institute for Health and Clinical Excellence’s willingness-to-pay threshold when compared to resuscitative thoracotomy with aortic cross-clamping, though REBOA still produced a 157 percent improvement in utility.35PubMed Central. A one-year cost-utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage These discrepancies likely reflect differences in healthcare system pricing, patient populations, and the comparators used, but they underscore that the financial case for REBOA is not as straightforward as the physiological case.
The device itself is not cheap, and the infrastructure required (trained operators, imaging capability, sheath kits kept stocked and ready) adds ongoing cost. For high-volume trauma centers that already maintain interventional capability, the marginal expense is modest. For smaller hospitals or prehospital services building a program from scratch, the calculus is harder to justify without clearer evidence of survival benefit.